FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038432715> ?p ?o ?g. }

• W2038432715 endingPage "684" @default.
• W2038432715 startingPage "679" @default.
• W2038432715 abstract "Background In this study we compared the immunogenicity of influenza vaccine administered intradermally to the standard intramuscular vaccination in lung transplant recipients. Methods Patients were randomized to receive the trivalent inactivated seasonal 2008–9 influenza vaccine containing either 6 μg (intradermal) or 15 μg (intramuscular) of hemagglutinin per viral strain. Immunogenicity was assessed by measurement of geometric mean titer of antibodies using the hemagglutination-inhibition (HI) assay. Vaccine response was defined as a 4-fold or higher increase of antibody titers to at least one vaccine antigen. Results Eighty-five patients received either the intradermal (n = 41) or intramuscular (n = 44) vaccine. Vaccine response was seen in 6 of 41 patients (14.6%) in the intradermal vs 8 of 43 (18.6%) in the intramuscular group (p = 0.77). Seroprotection (HI ≥1:32) was 39% for H1N1, 83% for H3N2 and 29% for B strain in the intradermal group vs 28% for H1N1, 98% for H3N2 and 58% for B strain in the intramuscular group (p = 0.36 for H1N1, p = 0.02 for H3N2, p < 0.01 for B). Mild adverse events were seen in 44% of patients in the intradermal group and 34% in the intramuscular group (p = 0.38). Conclusions Immunogenicity of the 2008–9 influenza vaccine given intradermally or intramuscularly was overall poor in lung transplant recipients. Novel strategies for influenza vaccination in this population are needed. In this study we compared the immunogenicity of influenza vaccine administered intradermally to the standard intramuscular vaccination in lung transplant recipients. Patients were randomized to receive the trivalent inactivated seasonal 2008–9 influenza vaccine containing either 6 μg (intradermal) or 15 μg (intramuscular) of hemagglutinin per viral strain. Immunogenicity was assessed by measurement of geometric mean titer of antibodies using the hemagglutination-inhibition (HI) assay. Vaccine response was defined as a 4-fold or higher increase of antibody titers to at least one vaccine antigen. Eighty-five patients received either the intradermal (n = 41) or intramuscular (n = 44) vaccine. Vaccine response was seen in 6 of 41 patients (14.6%) in the intradermal vs 8 of 43 (18.6%) in the intramuscular group (p = 0.77). Seroprotection (HI ≥1:32) was 39% for H1N1, 83% for H3N2 and 29% for B strain in the intradermal group vs 28% for H1N1, 98% for H3N2 and 58% for B strain in the intramuscular group (p = 0.36 for H1N1, p = 0.02 for H3N2, p < 0.01 for B). Mild adverse events were seen in 44% of patients in the intradermal group and 34% in the intramuscular group (p = 0.38). Immunogenicity of the 2008–9 influenza vaccine given intradermally or intramuscularly was overall poor in lung transplant recipients. Novel strategies for influenza vaccination in this population are needed." @default.
• W2038432715 created "2016-06-24" @default.
• W2038432715 creator A5011382706 @default.
• W2038432715 creator A5031999147 @default.
• W2038432715 creator A5040111709 @default.
• W2038432715 creator A5044322089 @default.
• W2038432715 creator A5044879111 @default.
• W2038432715 creator A5047171717 @default.
• W2038432715 creator A5047461358 @default.
• W2038432715 creator A5050197045 @default.
• W2038432715 creator A5057779932 @default.
• W2038432715 creator A5069476509 @default.
• W2038432715 creator A5076367801 @default.
• W2038432715 creator A5078694332 @default.
• W2038432715 date "2011-06-01" @default.
• W2038432715 modified "2023-09-27" @default.
• W2038432715 title "Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients" @default.
• W2038432715 cites W1485281795 @default.
• W2038432715 cites W1504466911 @default.
• W2038432715 cites W1964841465 @default.
• W2038432715 cites W1971278669 @default.
• W2038432715 cites W1977526385 @default.
• W2038432715 cites W1982450688 @default.
• W2038432715 cites W2016143593 @default.
• W2038432715 cites W2024435307 @default.
• W2038432715 cites W2033026307 @default.
• W2038432715 cites W2039688361 @default.
• W2038432715 cites W2048097566 @default.
• W2038432715 cites W2058161348 @default.
• W2038432715 cites W2065973683 @default.
• W2038432715 cites W2070159725 @default.
• W2038432715 cites W2087505711 @default.
• W2038432715 cites W2088750774 @default.
• W2038432715 cites W2090889765 @default.
• W2038432715 cites W2140146057 @default.
• W2038432715 cites W2142323141 @default.
• W2038432715 cites W2154402475 @default.
• W2038432715 cites W2157423084 @default.
• W2038432715 cites W4256309019 @default.
• W2038432715 cites W42629814 @default.
• W2038432715 doi "https://doi.org/10.1016/j.healun.2011.01.705" @default.
• W2038432715 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21377898" @default.
• W2038432715 hasPublicationYear "2011" @default.
• W2038432715 type Work @default.
• W2038432715 sameAs 2038432715 @default.
• W2038432715 citedByCount "46" @default.
• W2038432715 countsByYear W20384327152012 @default.
• W2038432715 countsByYear W20384327152013 @default.
• W2038432715 countsByYear W20384327152014 @default.
• W2038432715 countsByYear W20384327152015 @default.
• W2038432715 countsByYear W20384327152016 @default.
• W2038432715 countsByYear W20384327152017 @default.
• W2038432715 countsByYear W20384327152018 @default.
• W2038432715 countsByYear W20384327152019 @default.
• W2038432715 countsByYear W20384327152020 @default.
• W2038432715 countsByYear W20384327152021 @default.
• W2038432715 countsByYear W20384327152022 @default.
• W2038432715 crossrefType "journal-article" @default.
• W2038432715 hasAuthorship W2038432715A5011382706 @default.
• W2038432715 hasAuthorship W2038432715A5031999147 @default.
• W2038432715 hasAuthorship W2038432715A5040111709 @default.
• W2038432715 hasAuthorship W2038432715A5044322089 @default.
• W2038432715 hasAuthorship W2038432715A5044879111 @default.
• W2038432715 hasAuthorship W2038432715A5047171717 @default.
• W2038432715 hasAuthorship W2038432715A5047461358 @default.
• W2038432715 hasAuthorship W2038432715A5050197045 @default.
• W2038432715 hasAuthorship W2038432715A5057779932 @default.
• W2038432715 hasAuthorship W2038432715A5069476509 @default.
• W2038432715 hasAuthorship W2038432715A5076367801 @default.
• W2038432715 hasAuthorship W2038432715A5078694332 @default.
• W2038432715 hasConcept C126322002 @default.
• W2038432715 hasConcept C159047783 @default.
• W2038432715 hasConcept C159654299 @default.
• W2038432715 hasConcept C182072434 @default.
• W2038432715 hasConcept C197934379 @default.
• W2038432715 hasConcept C203014093 @default.
• W2038432715 hasConcept C22070199 @default.
• W2038432715 hasConcept C2776291583 @default.
• W2038432715 hasConcept C2780689484 @default.
• W2038432715 hasConcept C2780868878 @default.
• W2038432715 hasConcept C2908647359 @default.
• W2038432715 hasConcept C2909469553 @default.
• W2038432715 hasConcept C32611913 @default.
• W2038432715 hasConcept C71924100 @default.
• W2038432715 hasConcept C99454951 @default.
• W2038432715 hasConceptScore W2038432715C126322002 @default.
• W2038432715 hasConceptScore W2038432715C159047783 @default.
• W2038432715 hasConceptScore W2038432715C159654299 @default.
• W2038432715 hasConceptScore W2038432715C182072434 @default.
• W2038432715 hasConceptScore W2038432715C197934379 @default.
• W2038432715 hasConceptScore W2038432715C203014093 @default.
• W2038432715 hasConceptScore W2038432715C22070199 @default.
• W2038432715 hasConceptScore W2038432715C2776291583 @default.
• W2038432715 hasConceptScore W2038432715C2780689484 @default.
• W2038432715 hasConceptScore W2038432715C2780868878 @default.
• W2038432715 hasConceptScore W2038432715C2908647359 @default.
• W2038432715 hasConceptScore W2038432715C2909469553 @default.
• W2038432715 hasConceptScore W2038432715C32611913 @default.

• next